These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19504849)

  • 1. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetic maculopathy and lipid-lowering therapy.
    Misra A; Vikram NK; Kumar A
    Eye (Lond); 2004 Jan; 18(1):107-8. PubMed ID: 14707990
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.
    Duke Med Health News; 2009 Feb; 15(2):1, 11. PubMed ID: 19358321
    [No Abstract]   [Full Text] [Related]  

  • 5. Common obstacles in lipid management.
    Elpers M
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):287-95. PubMed ID: 18644511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting patients for statin therapy for the primary prevention of vascular events: what is the best approach?
    Mahoney EM
    Circulation; 2010 Oct; 122(15):1446-8. PubMed ID: 20876432
    [No Abstract]   [Full Text] [Related]  

  • 7. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-benefit analysis of the therapy of lipid metabolism disorders].
    Karádi I
    Orv Hetil; 1996 May; 137(21):1164. PubMed ID: 8757110
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug treatment of lipid disorders.
    Knopp RH
    N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607
    [No Abstract]   [Full Text] [Related]  

  • 10. Is exposure to HMG-CoA reductase inhibitors (statins), fibrates, or other lipid-lowering drugs associated with reduced risk of bone fracture in older patients?
    Douglas LO
    J Fam Pract; 2000 Sep; 49(9):849-50. PubMed ID: 11032211
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternate-day statin therapy for the treatment of hyperlipidemia.
    Reindl EK; Wright BM; Wargo KA
    Ann Pharmacother; 2010 Sep; 44(9):1459-70. PubMed ID: 20702760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 13. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
    Hebert LA; Rovin BH; Hebert CJ
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
    [No Abstract]   [Full Text] [Related]  

  • 14. [What other effects do statins have except their effect on lipids?].
    Tikkanen MJ
    Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hyperlipidemia in the elderly].
    Parhofer K
    MMW Fortschr Med; 2008 Nov; 150(47):31-3. PubMed ID: 19189453
    [No Abstract]   [Full Text] [Related]  

  • 16. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
    CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for aggressive lipid lowering: evidence from clinical trials.
    Farmer JA
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):305-9. PubMed ID: 15151477
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.